VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Vitacore, a deep technology company, today announced that it has received…
Strengthens cross-border investment and capital formation capabilities connecting the Middle East with global marketsNEW YORK and ABU DHABI, UAE, May 21,…
Elevates digital visualization for surgeons - ZEISS ARTEVO 850 surgical microscope provides ophthalmic surgeons in Mexico with advanced 3D visualization…
BEIJING, May 06, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the…
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…
April 10, 2026 16:09 ET | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…
Milestones underscore clinical progress and strengthen commercial foundationLOS GATOS, Calif., April 8, 2026 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage…
Offering a new, validated CCS design pathway, reducing uncertainty for cautious battery engineersNECKARSULM, Germany, March 25, 2026 /PRNewswire/ -- ENNOVI,…
NOIDA, India, March 13, 2026 /PRNewswire/ -- QuantPower, the AI-enabled algorithmic trading platform developed by Wisdom Tree Ventures Pvt. Ltd., has received…
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around…